Minocycline Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 67877-577

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Minocycline Hydrochloride (NDC 67877-577). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mino-105mg-30s (Mino 105mg 30s)

Mino-105mg-30s (Mino 105mg 30s)
This is a description of extended-release, film-coated tablets containing Minocycline Hydrochloride USP. Each tablet contains 105 mg of Minocycline. The usual adult dosage information is available in the package insert. The medication needs to be kept out of reach of children and dispensed in tight, light-resistant containers as defined in the USP. The tablets should be protected from light, moisture, and excessive heat and stored at 20° to 25°C. The manufacturer is Alkem Laboratories Ltd., Mumbai - 400 013, INDIA, while the distributor is Ascend Laboratories, LLC located in Parsippany, NJ 07054. The text also contains additional details about the product's label size, medication manufacturing, and certification numbers.*
FDA Label Image

Mino-115-30-countjpg (Mino 115 30 Countjpg)

Mino-115-30-countjpg (Mino 115 30 Countjpg)
This is a medication called Minocycline Hydrochloride USP, an extended-release tablet that contains 115mg of Minocycline. The tablet should be stored in a tight, light-resistant container, protected from light, moisture, and heat. The manufacturer is Alkem Laboratories Ltd. and it is distributed by Ascend Laboratories, LLC in Parsippany, NJ. Dosage information is included in the package insert, and it is important to keep this medication out of reach of children.*
FDA Label Image

Mino-135-30-count (Mino 135 30 Count)

Mino-135-30-count (Mino 135 30 Count)
This is a medication description for Minocycline Hydrochloride extended-release tablets, with each tablet containing 135 mg. The dosage information is available in the package insert, and it should be kept out of reach of children. The medication should be stored in light-resistant containers and protected from light, moisture, and excessive heat. The manufacturer is Alkem Laboratories Ltd. in Mumbai, India, and it is distributed by Ascend Laboratories in Parsippany, NJ. Rx only.*
FDA Label Image

Mino-45-30-count (Mino 45 30 Count)

Mino-45-30-count (Mino 45 30 Count)
This is a medication description for Minocycline Hydrochloride extended-release tablets manufactured by Alkem Laboratories Ltd. Each film-coated tablet contains 45mg of the active ingredient, Minocycline Hydrochloride. This medication is intended for adults and dosages should be followed as indicated in the package insert. The tablets should be dispensed in tight, light-resistant containers and stored between 20°C to 25°C to avoid exposure to light, moisture, and excessive heat. This medication is distributed by Ascend Laboratories, LLC in Parsippany, NJ, and is available in a package of 30 tablets.*
FDA Label Image

Mino-55mg-30s (Mino 55mg 30s)

Mino-55mg-30s (Mino 55mg 30s)
This is a medication description for Minocycline Hydrochloride extended-release tablets manufactured in India by Alkem Laboratories Ltd. and distributed in the U.S. by Ascend Laboratories, LLC. Each tablet contains 55mg of Minocycline Hydrochloride and is intended for adult use. The usual dosage information can be found in the package insert. The medication should be kept out of reach of children and stored in a tightly sealed, light-resistant container at controlled room temperature.*
FDA Label Image

Mino-65-30-countjpg (Mino 65 30 Countjpg)

Mino-65-30-countjpg (Mino 65 30 Countjpg)
This is a description of a medication called Minocycline Hydrochloride in extended-release, film-coated tablet form. Each tablet contains 65mg of minocycline. The usual adult dosage is provided in the package insert. The product comes in a 30-tablet pack and should be kept out of reach of children. It should be protected from light, moisture, and excessive heat and stored at a controlled room temperature. The medication is manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories, LLC in Parsippany, NJ. NDC 67877-643-30.*
FDA Label Image

Mino-80mg-30s (Mino 80mg 30s)

Mino-80mg-30s (Mino 80mg 30s)
This is a medication description of Minocycline Hydrochloride USP, an extended-release tablet used to treat various bacterial infections. Each tablet contains 80 mg of minocycline. The recommended adult dosage is available in the package insert. The medication should be kept away from children and stored in tight, light-resistant containers protected from light, moisture, and excessive heat at a temperature of 20° to 25°C. The manufacturer is Alkem Laboratories Ltd based in Mumbai, India, and it is distributed by Ascend Laboratories, LLC in Parsippany, NJ. The NDC number of the medication is 67877-437-30.*
FDA Label Image

Mino-90-30-count (Mino 90 30 Count)

Mino-90-30-count (Mino 90 30 Count)
Minocycline Hydrochloride Extended-Release Tablets are a prescription medication that comes in a 30-tablet container. Each tablet has 90 mg of Minocycline Hydrochloride USP. The package insert can be referred to for usual adult dosage. These tablets should be kept out of reach of children and dispensed in tight, light-resistant containers. Protect the tablets from light, moisture, and excessive heat. Store between 20°C to 25°C (68°F to 77°F) in a controlled room temperature conforming to USP. The manufacturing of these tablets is performed by Alkem Laboratories Ltd. located in Mumbai, India, and they are distributed by Ascend Laboratories in Parsippany, NJ.*
FDA Label Image

Mino-struc (Mino Structures)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.